NRG-BR003

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

For more information about this clinical trial, click here

Schema & Eligibility NRG-BR003

This trial is available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Care Cancer Center, Bolivar, MO
Cox Medical Center, Branson, MO
Freeman Health System, Joplin, MO
Phelps County Regional Medical Center, Rolla, MO
Mercy Hospital Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO
St. Louis Cancer & Breast Institute, St. Louis, MO
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL

Ask your physician about participating in this clinical trial or call us.